Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Drug-Related Side Effects and Adverse Reactions 19Head and Neck Neoplasms 15Lung Neoplasms 12Radiation Injuries 11Ovarian Neoplasms 10Leukemia 9Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Ovarian Epithelial 8Carcinoma, Non-Small-Cell Lung 8Leukemia, Myeloid, Acute 7Sarcoma 6Lymphoma, Non-Hodgkin 6Lymphoma 6Hodgkin Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Breast Neoplasms 5Neurotoxicity Syndromes 4Multiple Myeloma 4Xerostomia 3Waldenstrom Macroglobulinemia 3Uterine Cervical Neoplasms 3Testicular Neoplasms 3

Interventions

Methylprednisolone 3Etanercept 2tocilizumab 1pirfenidone 1ceftolozane, tazobactam drug combination 1XAV-19 1Ultrasonography 1Standard of Care 1Sodium Bicarbonate 1Saline Solution 1Ribavirin 1Prednisone 1Nebulizers and Vaporizers 1Lidocaine 1Immunoglobulin G 1Gelsolin 1Fluoridation 1Disulfides 1Clinical Protocols 1Calcitriol 1CIMAvax EGF 1Blood Specimen Collection 1Amifostine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pneumonia × Amifostine × Clear all
NCT00081315 2007-08-21

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

MedImmune LLC

Phase 2 Completed
130 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Esophagitis, Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡